Last updated on April 16, 2014 at 11:32 EDT

Latest Juno Therapeutics Inc. Stories

2014-01-13 16:25:48

Juno CEO Hans Bishop to Address JP Morgan's 32nd Annual Healthcare Conference SEATTLE, Jan. 13, 2014 /PRNewswire-USNewswire/ -- Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today an expanded Series A including Bezos Expeditions, the personal investment company of Jeff Bezos, and leading venture capital firm Venrock. The total Series A will exceed $145M. (Logo:...

2013-12-04 00:21:10

Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute join together to launch Juno Therapeutics Inc. Company founded with $120M initial investment, among largest fully committed Series A for a biotech startup in history Juno to develop broad pipeline of potentially revolutionary cancer immunotherapy products NEW YORK and SEATTLE, Dec. 4, 2013 /PRNewswire-USNewswire/ -- The Fred Hutchinson Cancer Research...